Apyx Medical (NASDAQ: APYX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.170 | -0.0200 | ||||
REV | 11.120M | 12.493M | 1.373M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Apyx Medical (NASDAQ: APYX) through any online brokerage.
Other companies in Apyx Medical’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), SI-BONE (NASDAQ:SIBN), Sight Sciences (NASDAQ:SGHT) and Apollo Endosurgery (NASDAQ:APEN).
The latest price target for Apyx Medical (NASDAQ: APYX) was reported by Lake Street on Friday, May 20, 2022. The analyst firm set a price target for 12.00 expecting APYX to rise to within 12 months (a possible 113.90% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Apyx Medical (NASDAQ: APYX) is $5.61 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Apyx Medical.
Apyx Medical’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Apyx Medical.
Apyx Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.